Almost throughout the history of mankind is a relentless struggle against pathogenic bacteria. And it is the tipping in one direction and then the other. The invention of antibiotics helped people to get ahead, but the germs have started to adapt to this, mutating and completely not responding to antibiotic therapy. Today increasingly need to develop new antibacterial drugs, but this is a very long (and expensive). And then the can help Hewlett-Packard with their bio-printers, which will accelerate the development of the means to save the life and health of people.
In recent years, the global scientific community is extremely concerned that an increasing number of superbugs that require a special approach in treatment. In fact, according to the world organization of Zdravookhranenie, only in North America each year, superbugs infected about 2 million people.
To combat this and accelerate testing of new drugs Center for control and prevention of diseases (CDC) purchased from Hewlett-Packard this HPD300e for use in laboratories in new York, Minnesota, Tennessee and Wisconsin. The main essence of the operation of these devices is that they work almost as well as conventional inkjet printers, but with one exception: instead of ink, they print the biological basis of living cells of a patient, where scientists can test various combinations of antibiotics, their effects on cells and on pathogenic bacteria that are settled in printed basics. As stated in the press service of the CDC in an interview with Engadget,
“To rescue and protect people, it is important to ensure the availability of the technology in laboratories across the country. We hope that our pilot project will increase the number of patients who recovered after Contracting superbugs.”
To discuss this and other news, you can in our official telegram chat.